- Home
- KROS vs OLP Comparison
KROS vs OLP Comparison
Compare KROS & OLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- OLP
- Stock Information
- Founded
- KROS 2015
- OLP 1982
- Country
- KROS United States
- OLP United States
- Employees
- KROS N/A
- OLP N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- OLP Real Estate Investment Trusts
- Sector
- KROS Health Care
- OLP Real Estate
- Exchange
- KROS Nasdaq
- OLP Nasdaq
- Market Cap
- KROS 565.0M
- OLP 483.3M
- IPO Year
- KROS 2020
- OLP N/A
- Fundamental
- Price
- KROS $15.62
- OLP $22.96
- Analyst Decision
- KROS Buy
- OLP
- Analyst Count
- KROS 14
- OLP 0
- Target Price
- KROS $20.56
- OLP N/A
- AVG Volume (30 Days)
- KROS 412.4K
- OLP 58.8K
- Earning Date
- KROS 11-05-2025
- OLP 11-04-2025
- Dividend Yield
- KROS N/A
- OLP 7.82%
- EPS Growth
- KROS N/A
- OLP N/A
- EPS
- KROS 0.47
- OLP 1.29
- Revenue
- KROS $232,844,000.00
- OLP $94,839,000.00
- Revenue This Year
- KROS $5,998.31
- OLP $11.08
- Revenue Next Year
- KROS N/A
- OLP $4.64
- P/E Ratio
- KROS $33.74
- OLP $17.85
- Revenue Growth
- KROS 85820.30
- OLP 7.07
- 52 Week Low
- KROS $9.12
- OLP $21.94
- 52 Week High
- KROS $72.37
- OLP $30.45
- Technical
- Relative Strength Index (RSI)
- KROS 57.13
- OLP 47.44
- Support Level
- KROS $15.34
- OLP $22.75
- Resistance Level
- KROS $15.85
- OLP $23.32
- Average True Range (ATR)
- KROS 0.45
- OLP 0.41
- MACD
- KROS -0.02
- OLP -0.04
- Stochastic Oscillator
- KROS 57.08
- OLP 27.07
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.